Design, synthesis and biological evaluation of chromone derivatives as novel protein kinase CK2 inhibitors

Bioorganic & Medicinal Chemistry Letters
2022.0

Abstract

Protein kinase CK2 is a potential target for the discovery of anticancer drugs. Flavonoids are reported to be effective CK2 inhibitors. Herein, based on structural trimming of flavonoids, a series of chromone-2-aminothiazole derivatives (1a-d, 2a-g, 4a-j, 5a-k) were designed and synthesized by hybridizing the chromone skeleton with 2-aminothiazole scaffold. Among these compounds, compound 5i was the most effective CK2 inhibitor (IC<sub>50</sub> = 0.08 μM) and possessed potent anti-proliferative activity against HL-60 tumor cells (IC<sub>50</sub> = 0.25 μM). Cellular thermal shift assay (CESTA) confirmed that 5i directly bound to the CK2, and the possible binding mode of 5i toward CK2 was also simulated. Further studies showed that 5i induced the apoptosis of HL-60 cells and arrested the cell cycle. Finally, western-blot analysis showed that 5i could inhibit the downstream of CK2, including α-catenin/Akt pathway and PARP/Survivin pathway.

Knowledge Graph

Similar Paper

Design, synthesis and biological evaluation of chromone derivatives as novel protein kinase CK2 inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2022.0
Design, syntheses, and antitumor activity of novel chromone and aurone derivatives
Bioorganic &amp; Medicinal Chemistry 2007.0
Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors
European Journal of Medicinal Chemistry 2021.0
Flavone-based arylamides as potential anticancers: Design, synthesis and in vitro cell-based/cell-free evaluations
European Journal of Medicinal Chemistry 2020.0
Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents
Bioorganic &amp; Medicinal Chemistry 2012.0
Towards the development of chromone-based MEK1/2 modulators
European Journal of Medicinal Chemistry 2014.0
Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors
European Journal of Medicinal Chemistry 2010.0
Design, synthesis and biological evaluation of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing sulfonamido as potential PI3Kα inhibitors
Bioorganic &amp; Medicinal Chemistry 2019.0
5,5′-Substituted Indirubin-3′-oxime Derivatives as Potent Cyclin-Dependent Kinase Inhibitors with Anticancer Activity
Journal of Medicinal Chemistry 2010.0
Novel potent pyrimido[4,5-c]quinoline inhibitors of protein kinase CK2: SAR and preliminary assessment of their analgesic and anti-viral properties
Bioorganic &amp; Medicinal Chemistry Letters 2011.0